BMJ 1995;310:110 (14 January)

Education and debate

Commentary: reserve acyclovir for secondary cases

Peter C Rubin 

Acyclovir is a safe drug that reduces the duration and severity of childhood chickenpox when started within 24 hours of the rash appearing. The case for using the drug in children who are immunocompromised (including those receiving steroids) is unanswerable. But I am not convinced that the drug should be used routinely in all children with chickenpox. The cost would be substantial and out of proportion to the benign course of most cases of the disease. Both authors make the point that secondary cases within a family are more severe and easier to identify earlier than the primary case. In an era of limited health care resources it seems more appropriate to reserve acyclovir for these secondary cases.--PETER C RUBIN, professor of therapeutics, University of Nottingham


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Education at prestigious centres is valuable
B S Drasar
BMJ 1995 310: 596. [Extract] [Full Text]

The tropical disease research programme has a coherent plan
S M Macleod
BMJ 1995 310: 596. [Extract] [Full Text]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ